Pharmaco-épidémiologie
mardi 24 juin 2025
Sessions parallèles
Sessions parallèles
•
S13
•
14h00
>
15h30
•
Pharmaco-épidémiologie
•
IFPS - Amphi 1
Sessions parallèles
Modérateurs : Julien BEZIN (Bordeaux), Margaux LAFAURIE (Toulouse)
Conférence invitée
14h00 La place des études de pharmaco-épidémiologie de terrain - Pernelle NOIZE (Bordeaux) et Sophie LIABEUF (Amiens)
Communications orales
•
39
•
CO-001 - Use and Potential Misuse of GLP-1 Receptor Agonists in France: a Nationwide Cohort Study
>
N.
Nathan
Du Soulier
•
143
•
CO-002 - Risk of Pervasive Developmental Disorders in Children Prenatally Exposed to Benzodiazepines
>
J.
Justine
Benevent
•
148
•
CO-003 - Asthma medication use in children exposed to gastric acid-suppressing drugs during early life: a study within the POMME cohort
>
T.
Tiffanie
Grime
•
168
•
CO-004 - Continuing TNFi after pregnancy diagnosis in women with chronic rheumatic inflammatory diseases is not associated with worse obstetrical or infectious outcomes: the results of an emulated target trial in the French Healthcare Data System (SNDS)
>
A.
Aya
Ajrouche
•
195
•
CO-005 - Ticagrelor and risk of sleep apnoea compared with other P2Y12 receptor inhibitors after acute coronary syndrome: A population-based cohort study
>
S.
Sarah Margot
Barras
•
203
•
CO-006 - Incidence of gabapentinoid use and misuse in France: a nationwide cohort study of new users
>
T.
Thomas
Soeiro
|